Lower In-Hospital Mortality with Plasma Exchange than Plasmapheresis in a Subgroup Analysis of 374 Lupus Patients

• Published in: BioMed research international Vol. 2018; no. 2018; pp. 1 - 8
• Main Authors: Chen, Jin-Bor, Hsu, Chung-Yuan, Chiu, Wen-Chan, Su, Yu-Jih, Ng, Hwee-Yeong
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2018; Hindawi; John Wiley & Sons, Inc
• Subjects: Adult; Apheresis; Autoimmune diseases; Biomedical research; Canada; Demography; Exchanging; Female; Guillain-Barre syndrome; Hepatitis; Homeostasis; Hospital Mortality; Humans; Immunoglobulins; Laboratories; Lupus; Lupus Erythematosus, Systemic - complications; Lupus Erythematosus, Systemic - mortality; Lupus Erythematosus, Systemic - therapy; Male; Mortality; Multivariate analysis; Patient outcomes; Patients; Peripheral neuropathy; Plasma Exchange - adverse effects; Plasma Exchange - mortality; Plasmapheresis; Plasmapheresis - adverse effects; Plasmapheresis - mortality; Rheumatic diseases; Rheumatology; Subgroups; Survival Analysis; Systemic lupus erythematosus; Canada; Japan

Background. Apheresis treatment includes plasmapheresis (PP) and plasma exchange (PE), and these terms are commonly used interchangeably. Nevertheless, the two procedures are carried out differently. The aims of this study were to investigate the mortality rate of patients who underwent therapeutic...